These impurity profiles are particular to a manufacturing route and may require control at both intermediate stages and in the final product
Together, these effects create a powerful combination
Regular check-ins allow for dose optimization, side effect management, and ongoing support throughout your journey
In our extensive nationwide population study, we did not observe an increased risk of developing all thyroid cancers, including MTC, in patients with T2DM treated with GLP-1 RAs compared to those not receiving these agents
Adults take 1 capsule once or twice per day on an empty stomach, or as directed by your qualified healthcare professional
Risk ratios (RR) for the renal outcome estimates according to direct (DPP-4 inhibitors, GLP-1RA and SGLT-2 inhibitors against placebo) and indirect (DPP-4 inhibitors vs GLP-1RA or SGLT-2 inhibitors, and GLP-1RA vs SGLT-2 inhibitors) comparisons